ENTRY       D09948                      Drug
NAME        Plecanatide (USAN/INN);
            Trulance (TN)
PRODUCT     TRULANCE (Salix Pharmaceuticals)
            TRULANCE (Synergy Pharmaceuticals)
FORMULA     C65H104N18O26S4
EXACT_MASS  1680.6252
MOL_WEIGHT  1681.8863
SEQUENCE    Asn Asp Glu Cys Glu Leu Cys Val Asn Val Ala Cys Thr Gly Cys Leu
            (Disulfide bridge: 4-12, 7-15)
  TYPE      Peptide
REMARK      ATC code: A06AX07
            Product: D09948<US>
EFFICACY    Peristaltic accelerator, Enterotoxin receptor agonist
  DISEASE   Irritable bowel syndrome [DS:H01615]
COMMENT     synthetic analog of Uroguanylin [CPD:C16006]
            Chronic constipation, irritable bowel syndrome with constipation
TARGET      GUCY2C [HSA:2984] [KO:K12320]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A06 DRUGS FOR CONSTIPATION
               A06A DRUGS FOR CONSTIPATION
                A06AX Other drugs for constipation
                 A06AX07 Plecanatide
                  D09948  Plecanatide (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Gastrointestinal Agents
              Anti-Constipation Agents
               Plecanatide
                D09948  Plecanatide (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Lyases (EC4)
               Phosphorus-oxygen lyases
                GUCY2C
                 D09948  Plecanatide (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09948
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09948
DBLINKS     CAS: 467426-54-6
            PubChem: 124490630
///
